Syria reported its first confirmed case of swine influenza or A-H1N1 on July 4, according to the Voice of America. Syrian health officials said that the case was detected in a Syrian woman who flew to the country from Australia.
The first death from H1N1 was confirmed on August 26. Syrian Arab News Agency (SANA) quoted the Health Ministry as saying a Syrian man had died of the strain.

Useful, but no Drug replacement: Street Cleaning in Aleppo, Syria
Syrian News Station, a news website frequently quoted by international newspapers, reports that vaccines should be available in Syria in December. Syrian health minister cited safety reasons for not starting large-scale vaccinations earlier. The country recorded 122 infections by October 20.
According to Taiwan Today (quoting the China Times), Taiwanese drug manufacturer Adimmune was approached by Southeast Asian and Middle Eastern countries which were unable to purchase H1N1 vaccines from other nations, but the company’s ceo Ignatius Wei said that Adimmune’s main concern was the welfare of Taiwan’s citizens.
Adimmune did not specify which countries were among its Middle Eastern contacts. While Syria’s infection numbers have risen since June, it may still be in a more comfortable situation than most of its neighbours if the trends have remained the same. As of June this year, Syria’s number of confirmed infections was much smaller than those of most of its neighbours.







